Fundraising Fox

TrialScope

Jersey City, US · Founded 2012 · Delaware corporation · 1 known investors

Find your way into TrialScope

Biotech

Founders & leadership

MH
Mark HeinoldinChief Executive Officer2016–2018
RA
Richard AguinaldoExecutive
EM
E. Michael ForgashExecutive

Board

MA
Michael A DiPianoBoard directorExecutive Officer at NewSpring Capital
EJ
Eric JensenBoard director
JS
Joe StaufferBoard director
MBMichael Balmuth
Michael BalmuthinBoard Of DirectorsManaging Partner at SV Health Investors
JK
Jeffrey KozloffBoard director
JHJames Hill
James HillinBoard Member2014–2019General Partner at Grand Ventures
CS
Charles SaldariniBoard director
CN
Christopher NoeBoard director
JC
James C WalkerBoard director

Investors · 1

NewSpring CapitalreportedRadnor

Reported raises · per SEC filings

Form D private placements

$17.8M disclosed across 3 rounds · 2014–2018

▶$4MraisedSep 2018 · 5 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Jeffrey KozloffExecutive Officer, Director
  • Marc LedermanDirector
  • Matthew PatrasExecutive Officer
  • James C. WalkerDirector
  • Larry BerranDirector
  • Michael KopelmanDirector
Offering amount
$4.5M
Amount sold
$4M
First sale
Sep 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.6MraisedApr 2017 · 6 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Jeffrey KozloffDirector
  • Michael A DiPianoDirector
  • Mark HeinoldExecutive Officer, Director
  • James HillDirector
  • Charles SaldariniDirector
  • Richard AguinaldoExecutive Officer
  • Christopher NoeDirector
  • James C WalkerDirector
Offering amount
$4M
Amount sold
$3.6M
First sale
Apr 2017
Incorporated
Corporation, Delaware, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$10.2MraisedJun 2014 · 4 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Jim WalkerDirector
  • Eric JensenDirector
  • Joe StaufferDirector
  • Michael BalmuthDirector
  • Chris NoeDirector
  • E. Michael ForgashExecutive Officer, Director
Offering amount
$10.2M
Amount sold
$10.2M
First sale
May 2014
Incorporated
Corporation, Delaware, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

TrialScope Turns to NOL Program, Venture Fund Investment as it Supports Clinical Trials Worldwide - NJEDAnjeda.gov · Jun 2019TrialScope 9/18/2018 Capital Raise - Gaebler.com Venture Capital Databasegaebler.com · Sep 2018TrialScope Acquires PharmaCM Platformmddionline.com · Jun 2014Edison Ventures Announces Investment in TrialScopeglobenewswire.com · Jun 2014TrialScope Raises more than $10M - FinSMEsfinsmes.com · Jun 2014

Frequently asked questions

Who are TrialScope's investors?
TrialScope's investors include NewSpring Capital.
How much funding has TrialScope raised?
TrialScope has disclosed $17.8M raised across 3 rounds.
Where is TrialScope headquartered?
TrialScope is headquartered in Jersey City, US.